कोशिश गोल्ड - मुक्त

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

Bio Spectrum

|

August 2025

India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

India stands as the fourth-largest medical devices market in Asia, trailing only Japan, China, and South Korea, and is counted among the top 20 markets worldwide. The sector is broadly categorised into five key segments: electronic equipment (56 per cent), disposables and consumables (26.5 per cent), in-vitro diagnostics (8.1 per cent), implants (7.1 per cent), and surgical instruments (2.3 per cent). (Source: Invest India)

Most domestic manufacturers are concentrated in the disposables and consumables segment, primarily serving local demand. In contrast, high-end categories such as electronic equipment remain dominated by multinational companies. The domestic industry comprises around 800 manufacturers, with production still focused on a limited set of product areas.

In 2023-24, India's medical device exports crossed $4 billion, which is an impressive number on its own, but compared to imports which stood at nearly double, at $8.1 billion, it highlights the country's continued reliance on foreign medical technologies, with nearly 80 per cent of its medical device requirements still met through imports.

To address this imbalance and expand domestic manufacturing capacity, the government has set a goal to reduce import dependence to below 50 per cent over the next five years and has announced a slew of initiatives, investments, and incentives.

Government Initiatives: Have they moved the needle?

Bio Spectrum से और कहानियाँ

Bio Spectrum

New England Biolabs launches NEBNext low-bias small RNA library prep kit

US-based New England Biolabs (NEB) has announced the launch of the NEBNext Low-bias Small RNA Library Prep Kit, designed to minimise biased representation of small RNA species in sequencing data.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Qiagen expands NGS portfolio with launch of QIAseq XHYB long read panels

Qiagen has announced the launch of its new QIAseq xHYB Long Read Panels, a suite of target enrichment solutions designed to unlock long-read sequencing of genomically complex regions.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Iberia Pharma set to open manufacturing unit in India with investment of Rs 70 Cr

Gurugram-based Iberia Pharmaceuticals has announced its new hi-tech manufacturing and research facility spread across 60,000 sq. ft. in Jhajjar, Haryana.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

Al/loT-Driven Real-time Cardiac Event Prediction & Treatment

It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.

time to read

2 mins

September 2025

Bio Spectrum

SCHOTT announces launch of syringe and cartridge glass tubing in India

SCHOTT, a global pioneer in specialty glass, has announced the addition of syringe and cartridge glass tubing to its existing state-ofthe-art manufacturing capabilities in Jambusar, Gujarat.

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

ICMR expands collaborative partnership with CEPI for vaccine research

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Indian Council of Medical Research (ICMR) have expanded their collaborative partnership through a newly signed Memorandum of Understanding (MOU).

time to read

1 min

September 2025

Bio Spectrum

Bio Spectrum

AMTZ to open India's first advanced 3D printing hub for orthopaedic implants

In a landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) have announced a strategic partnership to establish India's most advanced orthopaedic implant manufacturing facility powered by 3D printing and precision engineering.

time to read

1 min

September 2025

Bio Spectrum

Alveolus Bio secures strategic investment from Shilpa Medicare

Alveolus Bio, a US-based respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham, has announced a strategic financing round led by Raichur-based Shilpa Medicare, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.

time to read

1 min

September 2025

Bio Spectrum

JNCASR explores potential cure for Alzheimer's Disease

Researchers from Bengaluru-based Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute of the Department of Science and Technology (DST) have explored altered miRNAs in the Alzheimer's Disease (AD) brain and also probed the potential of miRNAs to be biomarkers for early, specific and accurate clinical diagnosis of AD.

time to read

1 min

September 2025

Bio Spectrum

Aster DM Healthcare to inject Rs 580 Cr to build 5th hospital in Bengaluru

Aster DM Healthcare, one of India's leading integrated healthcare providers, in a move to strengthen its footprint in one of India's fastest-growing healthcare hubs, Bengaluru, has announced Rs 580 crore investment to develop a state-of-the-art, 500-bed multi-specialty hospital in Yeshwanthpur.

time to read

1 min

September 2025

Listen

Translate

Share

-
+

Change font size